BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28605463)

  • 1. Stereotactic Radiosurgery and Hypofractionated Radiotherapy for Glioblastoma.
    Shah JL; Li G; Shaffer JL; Azoulay MI; Gibbs IC; Nagpal S; Soltys SG
    Neurosurgery; 2018 Jan; 82(1):24-34. PubMed ID: 28605463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Hypofractionation Radiation Strategies for Glioblastoma.
    Azoulay M; Shah J; Pollom E; Soltys SG
    Curr Oncol Rep; 2017 Sep; 19(9):58. PubMed ID: 28735440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.
    Pollom EL; Fujimoto D; Wynne J; Seiger K; Modlin LA; Jacobs LR; Azoulay M; von Eyben R; Tupper L; Gibbs IC; Hancock SL; Li G; Chang SD; Adler JR; Harsh GR; Harraher C; Nagpal S; Thomas RP; Recht LD; Choi CYH; Soltys SG
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):123-130. PubMed ID: 28586949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO).
    Scoccianti S; Krengli M; Marrazzo L; Magrini SM; Detti B; Fusco V; Pirtoli L; Doino D; Fiorentino A; Masini L; Greto D; Buglione M; Rubino G; Lonardi F; Migliaccio F; Marzano S; Santoni R; Ricardi U; Livi L
    Radiol Med; 2018 Jan; 123(1):48-62. PubMed ID: 28879459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis.
    Trone JC; Vallard A; Sotton S; Ben Mrad M; Jmour O; Magné N; Pommier B; Laporte S; Ollier E
    Radiat Oncol; 2020 Jun; 15(1):145. PubMed ID: 32513205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of recurrent glioblastoma with stereotactic radiotherapy: long-term results of a mono-institutional trial.
    Maranzano E; Anselmo P; Casale M; Trippa F; Carletti S; Principi M; Loreti F; Italiani M; Caserta C; Giorgi C
    Tumori; 2011; 97(1):56-61. PubMed ID: 21528665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery for glioblastoma: a final report of 31 patients.
    Masciopinto JE; Levin AB; Mehta MP; Rhode BS
    J Neurosurg; 1995 Apr; 82(4):530-5. PubMed ID: 7897511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy.
    Holt DE; Bernard ME; Quan K; Clump DA; Engh JA; Burton SA; Heron DE
    J Cancer Res Ther; 2016; 12(4):1243-1248. PubMed ID: 28169234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and recent advances in reirradiation of glioblastoma.
    Minniti G; Niyazi M; Alongi F; Navarria P; Belka C
    Radiat Oncol; 2021 Feb; 16(1):36. PubMed ID: 33602305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypofractionated stereotactic radiotherapy for brain metastasis: Benefit of additional whole brain radiotherapy?].
    Royer P; Salleron J; Vogin G; Taillandier L; Clément-Duchêne C; Klein O; Faivre JC; Peiffert D; Bernier V
    Cancer Radiother; 2017 Dec; 21(8):731-740. PubMed ID: 28711413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.
    Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluating stereotactic radiosurgery for glioblastoma: new potential for targeted dose-escalation.
    Yanagihara TK; Saadatmand HJ; Wang TJ
    J Neurooncol; 2016 Dec; 130(3):397-411. PubMed ID: 27632018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosurgery for Glioblastoma.
    Bunevicius A; Sheehan JP
    Neurosurg Clin N Am; 2021 Jan; 32(1):117-128. PubMed ID: 33223020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-irradiation with radiosurgery for recurrent glioblastoma multiforme.
    Torok JA; Wegner RE; Mintz AH; Heron DE; Burton SA
    Technol Cancer Res Treat; 2011 Jun; 10(3):253-8. PubMed ID: 21517131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
    J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.
    Jablonska PA; Diez-Valle R; Pérez-Larraya JG; Moreno-Jiménez M; Idoate MÁ; Arbea L; Tejada S; Garcia de Eulate MR; Ramos L; Arbizu J; Domínguez P; Aristu JJ
    PLoS One; 2019; 14(6):e0217881. PubMed ID: 31170245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated stereotactic radiotherapy for brain metastases from lung cancer : Evaluation of indications and predictors of local control.
    Ishihara T; Yamada K; Harada A; Isogai K; Tonosaki Y; Demizu Y; Miyawaki D; Yoshida K; Ejima Y; Sasaki R
    Strahlenther Onkol; 2016 Jun; 192(6):386-93. PubMed ID: 27169391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Tumours in Children and Young Adults.
    Chandy E; Taylor H; Gaito S; Wells E; Jones C; Meehan C; Burland H; Stone J; Snowball C; Mashru J; Riddell C; Hon Y; Welsh L; Saran F; Mandeville H
    Clin Oncol (R Coll Radiol); 2020 May; 32(5):316-326. PubMed ID: 31813663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.